Developing treatments for impaired cognition in schizophrenia

Michael J. Minzenberg, Cameron S Carter

Research output: Contribution to journalArticle

71 Citations (Scopus)

Abstract

Schizophrenia is one of the most debilitating of all common brain disorders, exacting a heavy toll on the afflicted and having a tremendous public health impact. Clinical outcome is more strongly predicted by cognitive deficits than psychotic symptoms, with no established treatment for these deficits. In this review, we discuss the status of treatment development for impaired cognition in schizophrenia. These treatments include a range of pharmacological targets within diverse neurotransmitter systems. New technologies, including transcranial magnetic stimulation and transcranial direct current stimulation, and psychological therapies, such as computer-based cognitive training, may also benefit cognition in schizophrenia. Each of these approaches shows promise and their integration may optimize benefits for patients in the future.

Original languageEnglish (US)
Pages (from-to)35-42
Number of pages8
JournalTrends in Cognitive Sciences
Volume16
Issue number1
DOIs
StatePublished - Jan 2012

Fingerprint

Cognition
Schizophrenia
Transcranial Magnetic Stimulation
Brain Diseases
Therapeutics
Neurotransmitter Agents
Public Health
Pharmacology
Psychology
Technology

ASJC Scopus subject areas

  • Cognitive Neuroscience
  • Experimental and Cognitive Psychology
  • Neuropsychology and Physiological Psychology

Cite this

Developing treatments for impaired cognition in schizophrenia. / Minzenberg, Michael J.; Carter, Cameron S.

In: Trends in Cognitive Sciences, Vol. 16, No. 1, 01.2012, p. 35-42.

Research output: Contribution to journalArticle

@article{33d72f2b6c2742c1b0cab06546f00808,
title = "Developing treatments for impaired cognition in schizophrenia",
abstract = "Schizophrenia is one of the most debilitating of all common brain disorders, exacting a heavy toll on the afflicted and having a tremendous public health impact. Clinical outcome is more strongly predicted by cognitive deficits than psychotic symptoms, with no established treatment for these deficits. In this review, we discuss the status of treatment development for impaired cognition in schizophrenia. These treatments include a range of pharmacological targets within diverse neurotransmitter systems. New technologies, including transcranial magnetic stimulation and transcranial direct current stimulation, and psychological therapies, such as computer-based cognitive training, may also benefit cognition in schizophrenia. Each of these approaches shows promise and their integration may optimize benefits for patients in the future.",
author = "Minzenberg, {Michael J.} and Carter, {Cameron S}",
year = "2012",
month = "1",
doi = "10.1016/j.tics.2011.11.017",
language = "English (US)",
volume = "16",
pages = "35--42",
journal = "Trends in Cognitive Sciences",
issn = "1364-6613",
publisher = "Elsevier Limited",
number = "1",

}

TY - JOUR

T1 - Developing treatments for impaired cognition in schizophrenia

AU - Minzenberg, Michael J.

AU - Carter, Cameron S

PY - 2012/1

Y1 - 2012/1

N2 - Schizophrenia is one of the most debilitating of all common brain disorders, exacting a heavy toll on the afflicted and having a tremendous public health impact. Clinical outcome is more strongly predicted by cognitive deficits than psychotic symptoms, with no established treatment for these deficits. In this review, we discuss the status of treatment development for impaired cognition in schizophrenia. These treatments include a range of pharmacological targets within diverse neurotransmitter systems. New technologies, including transcranial magnetic stimulation and transcranial direct current stimulation, and psychological therapies, such as computer-based cognitive training, may also benefit cognition in schizophrenia. Each of these approaches shows promise and their integration may optimize benefits for patients in the future.

AB - Schizophrenia is one of the most debilitating of all common brain disorders, exacting a heavy toll on the afflicted and having a tremendous public health impact. Clinical outcome is more strongly predicted by cognitive deficits than psychotic symptoms, with no established treatment for these deficits. In this review, we discuss the status of treatment development for impaired cognition in schizophrenia. These treatments include a range of pharmacological targets within diverse neurotransmitter systems. New technologies, including transcranial magnetic stimulation and transcranial direct current stimulation, and psychological therapies, such as computer-based cognitive training, may also benefit cognition in schizophrenia. Each of these approaches shows promise and their integration may optimize benefits for patients in the future.

UR - http://www.scopus.com/inward/record.url?scp=84855297354&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84855297354&partnerID=8YFLogxK

U2 - 10.1016/j.tics.2011.11.017

DO - 10.1016/j.tics.2011.11.017

M3 - Article

VL - 16

SP - 35

EP - 42

JO - Trends in Cognitive Sciences

JF - Trends in Cognitive Sciences

SN - 1364-6613

IS - 1

ER -